Short term effects of doxycycline on matrix metalloproteinases 2 and 9

Cardiovasc Drugs Ther. 2009 Apr;23(2):153-9. doi: 10.1007/s10557-008-6150-7. Epub 2008 Dec 4.

Abstract

Purpose: To investigate the short term effects of Doxycycline on MMP-2 and MMP-9.

Methods: Short term effects of Doxycycline (100 mg B.I.D.) on plasma levels of MMP-2 and MMP-9 were investigated in 20 healthy subjects; the effects of Doxy, Acetylsalicylic acid, Nitrates, and Enalapril on MMP-9 release from were assessed in isolated polymorphonuclear cells.

Results: In plasma, MMP-9 activity was reduced (-22%, 95% CI -32/-11; P = 0.002) starting at 12 h after doxy; in vitro, MMP-9 released from stimulated neutrophils was reduced by Doxy (-28%, 95% CI -43/-14; P = 0.001), inhibiting degranulation, and by nitrates (-52%, 95% CI -76/-28 P = 0.005), increasing three times both pro- and active-MMP-9 bound to neutrophils (P = 0.007 and 0.040, respectively).

Conclusions: Doxy decreases MMP-9 plasma levels by around 20%, within the first 12 h. The mechanism leading to such reduction seems due to the inhibition of PMN degranulation.

Publication types

  • Clinical Trial
  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anti-Bacterial Agents / pharmacology*
  • Aspirin / pharmacology
  • Cell Degranulation / drug effects
  • Doxycycline / pharmacology*
  • Enalapril / pharmacology
  • Female
  • Humans
  • Male
  • Matrix Metalloproteinase 2 / drug effects*
  • Matrix Metalloproteinase 2 / metabolism
  • Matrix Metalloproteinase 9 / drug effects*
  • Matrix Metalloproteinase 9 / metabolism
  • Neutrophils / drug effects
  • Neutrophils / enzymology
  • Nitrates / pharmacology
  • Time Factors

Substances

  • Anti-Bacterial Agents
  • Nitrates
  • Enalapril
  • Matrix Metalloproteinase 2
  • Matrix Metalloproteinase 9
  • Doxycycline
  • Aspirin